Scienture Holdings is no longer the old TRxADE wholesale marketplace. The Commack specialty company now lives or dies on whether two newly approved reformulations can scale before a listing clock and a secured-note clock close in. Co-chief executives Narasimhan Mani and Shankar Hariharan spent the second quarter converting Arbli, the first Food and Drug Administration-approved liquid losartan, from a stocking curiosity into a repeating wholesale order book, then brought REZENOPY, the highest-dose approved naloxone nasal spray, into commercial shipment. The debate is not whether the products exist. The debate is whether a still-tiny commercial engine can outrun cash use, a Nasdaq bid-price deadline, and monthly redemption rights on a Streeterville facility.
The sequential revenue jump looks dramatic only because the starting base was almost nothing. Second-quarter product sales reached $344 thousand after a first-quarter print of $56 thousand. The gross margin sat near ninety-eight percent because the cost of a ready-to-use oral suspension is trivial next to the wholesale invoice. That unit economics story is real. It is also incomplete. Operating expenses still ran about $3 million in the quarter. The operating loss was still about $3 million. Two wholesale customers accounted for more than four-fifths of the top line. High-margin launch revenue that depends on two distributors is not yet a franchise.
Unrestricted cash sat near $8 million at mid-year. Another $3 million sat locked in a lender-controlled account. Combined cash and restricted cash of about $11 million funds a first-half cash burn that still measured in the millions. Management states that existing cash, Arbli reorders, and the REZENOPY launch cover the next twelve months. The same filing still carries substantial-doubt going-concern language. The question the next two quarters resolve is simple. Do wholesale reorders compound fast enough to shrink the cash hole before Streeterville can start monthly redemptions and before the autumn bid-price deadline forces a reverse split?